Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Dec 28;15(12):e0244401.
doi: 10.1371/journal.pone.0244401. eCollection 2020.

Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses

Affiliations
Comparative Study

Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses

Danielle Rice et al. PLoS One. .

Abstract

Background: Guidelines recommend that individuals with opioid use disorder (OUD) receive pharmacological and psychosocial interventions; however, the most appropriate psychosocial intervention is not known. In collaboration with people with lived experience, clinicians, and policy makers, we sought to assess the relative benefits of psychosocial interventions as an adjunct to opioid agonist therapy (OAT) among persons with OUD.

Methods: A review protocol was registered a priori (CRD42018090761), and a comprehensive search for randomized controlled trials (RCT) was conducted from database inception to June 2020 in MEDLINE, Embase, PsycINFO and the Cochrane Central Register of Controlled Trials. Established methods for study selection and data extraction were used. Primary outcomes were treatment retention and opioid use (measured by urinalysis for opioid use and opioid abstinence outcomes). Odds ratios were estimated using network meta-analyses (NMA) as appropriate based on available evidence, and in remaining cases alternative approaches to synthesis were used.

Results: Seventy-two RCTs met the inclusion criteria. Risk of bias evaluations commonly identified study limitations and poor reporting with regard to methods used for allocation concealment and selective outcome reporting. Due to inconsistency in reporting of outcome measures, only 48 RCTs (20 unique interventions, 5,404 participants) were included for NMA of treatment retention, where statistically significant differences were found when psychosocial interventions were used as an adjunct to OAT as compared to OAT-only. The addition of rewards-based interventions such as contingency management (alone or with community reinforcement approach) to OAT was superior to OAT-only. Few statistically significant differences between psychosocial interventions were identified among any other pairwise comparisons. Heterogeneity in reporting formats precluded an NMA for opioid use. A structured synthesis was undertaken for the remaining outcomes which included opioid use (n = 18 studies) and opioid abstinence (n = 35 studies), where the majority of studies found no significant difference between OAT plus psychosocial interventions as compared to OAT-only.

Conclusions: This systematic review offers a comprehensive synthesis of the available evidence and the limitations of current trials of psychosocial interventions applied as an adjunct to OAT for OUD. Clinicians and health services may wish to consider integrating contingency management in addition to OAT for OUD in their settings to improve treatment retention. Aside from treatment retention, few differences were consistently found between psychosocial interventions adjunctive to OAT and OAT-only. There is a need for high-quality RCTs to establish more definitive conclusions.

Trial registration: PROSPERO registration CRD42018090761.

PubMed Disclaimer

Conflict of interest statement

BH has previously received honoraria from Eversana (previously Cornerstone Research Group) for the provision of methodologic advice related to systematic reviews and meta-analysis. This does not alter the adherence to PLOS Medicine policies on sharing data and materials. All other authors have no conflicts of interest to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Process of study selection.
A flow diagram is shown which depicts the process of study selection.
Fig 2
Fig 2. Type of psychosocial interventions.
The number and type of different psychosocial interventions that were assessed across the set of included studies is presented.
Fig 3
Fig 3. Outcomes reported in included studies.
The extent to which the outcomes of a priori interest were reported for each eligible treatment arm across the set of included studies are presented.
Fig 4
Fig 4. Network diagram of treatment retention.
The evidence network of the available studies and interventions for treatment retention as a binary outcome is shown. Joining lines denote treatment comparisons where one or more trials were available. Nodes are proportionally sized to reflect the numbers of patients studied with each intervention. Edge width reflects the number of RCTs for each comparison.
Fig 5
Fig 5. Forest plots of treatment retention.
Forest plots of psychosocial treatments versus the reference group, OAT only, is presented.

References

    1. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487–1492. - PubMed
    1. Centers for Disease Control and Prevention. Opioid Overdose Understanding the epidemic. Atlanta, Centers for Disease Control and Prevention; 2018.
    1. Donroe JH, Socias ME, Marshall BD. The deepening opioid crisis in North America: historical context and current solutions. Current Addiction Reports. 2018;5(4):454–463.
    1. Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2015. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017. - PubMed
    1. Becker WC, Fiellin DA. When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis In: American College of Physicians; 2020. - PMC - PubMed

MeSH terms

Substances

Grants and funding